Oregon Freeze Dry (OFD) Life Sciences announced multiple leadership appointments to its recently created Life Sciences division and the appointment of CDMO veteran Jim Miller to its board of directors.

Announced in December 2024, David Enloe joins as the division’s CEO. He has experience leading life science CDMOs such as Vivante GMP Solutions, Lonza, Althea, Ajinomoto Bio-Pharma Services, and Societal CDMO through build and growth phases.

Walter Pebley, Ph.D., has been appointed Chief Scientific Officer. His work has been at the forefront of OFD’s innovations in lyophilization and he has been solving problems and creating solutions for OFD customers for over 40 years.

Erica Raether has been appointed Chief People Officer. She brings over 20 years of experience in increasing levels of responsibility in human capital leadership with biopharma CDMO and medical device companies, including Althea, Ajinomoto Bio-Pharma Services, and Societal CDMO.

Shawna Monsoor joined as a VP of Business Development. She brings nearly 20 years of commercial experience in life sciences. Monsoor spent 13 years as a commercial leader at Thermo Fisher Patheon, Ajinomoto, Abzena, Alcami, and Adare.

Dan Peizer joined the company as a VP of Business Development for OFD Life Sciences. He has over 25 years of sales and marketing experience in life sciences across the animal health, consumer health, and pharma segments with Bayer and, most recently at Catalent, where he held leadership roles in both sales and marketing.

Miller is a recognized expert in biopharmaceutical CDMOs with nearly 50 years of experience. During his career, he established and presided over the industry’s principal online database on biopharmaceutical contract manufacturing intelligence, PharmSource Strategic Advantage.